Further behavioural evidence for the selective sedative action of zolpidem
References (28)
- et al.
High affinity 3H-zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors
Eur. J. Pharmac.
(1986) - et al.
A comparison of the effects of some benzodiazepines and other drugs on aggressive and exploratory behaviour in mice and rats
Neuropharmacology
(1970) Benzodiazepines as appetite-enhancing compounds
Appetite
(1980)- et al.
Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors
Neurosci. Biobehav. Rev.
(1985) What can be learned from the effects of benzodiazepines on exploratory behavior?
Neurosci. Biobehav. Rev.
(1985)- et al.
Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone
Pharmac. Biochem. Behav.
(1985) Investigation of the actions of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 using the schedule-controlled behavior of rats
Pharmac. Biochem. Behav.
(1986)- et al.
The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure
Physiol. Behav.
(1987) Animal models for the study of antianxiety agents: a review
Neurosci. Biobehav. Rev.
(1985)Molecular aspects of the action of benzodiazepine and non-benzodiazepine anxiolytics: a hypothetical allosteric model of the benzodiazepine receptor complex
Prog. Neuropsychopharmac. Biol. Psychiat.
(1984)
Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats
Naunyn. Schmiedebergs Arch. Pharmac.
(1985)
In vivo interaction of zolpidem with central benzodiazepine binding sites (as labelled by 3H-Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the ω1 (BZ1) subtype
J. Pharmac. exp. Ther.
(1988)
A non benzodiazepine, non sedating potential anxiolytic
Drug Devel. Res.
(1984)
Hypertonic saline intake in the rat after administration of 5-HT1A agonists, benzodiazepine partial agonists and zolpidem
Cited by (39)
Zolpidem-induced changes in activity, metabolism, and anxiety in rats
2011, Pharmacology Biochemistry and BehaviorCitation Excerpt :Zolpidem (Ambien) is a nonbenzodiazepine drug commonly used for the treatment of insomnia. It has been shown to have observable sedative and hypnotic effects in humans (Nicholson and Pascoe, 1986) and animals (Sanger and Zivkovic, 1988). As a hypnotic drug, it works by slowing activity in the brain to allow sleep, and it is used in the temporary treatment of insomnia characterized by difficulties with sleep initiation (Nicholson and Pascoe, 1986; Wilson and Nutt, 2007).
Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm
2004, Pharmacology Biochemistry and BehaviorBehavioral effects of acute and chronic triazolam treatments in albino rats
2003, Life SciencesThe open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review
2003, European Journal of PharmacologyThe abuse potential of zolpidem administered alone and with alcohol
1998, Pharmacology Biochemistry and BehaviorComparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem
1996, European Journal of Pharmacology
Copyright © 1988 Published by Elsevier Ltd.